Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies Reply

被引：4
|
作者：
Sauter, Guido [1 ]
Lee, James A. [2 ]
Slamon, Dennis J. [3 ]
Press, Michael F. [4 ,5 ]
机构：
[1] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
[2] Altarum Inst, Ann Arbor, MI USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 05期
关键词：
COST-EFFECTIVENESS ANALYSIS; RECEPTOR; 2; ASSESSMENT; GENE AMPLIFICATION; IMMUNOHISTOCHEMICAL ASSAY; FISH; TRASTUZUMAB; CONCORDANCE; CARCINOMAS; EXPRESSION; HERCEPTEST;
D O I：
10.1200/JCO.2009.25.3930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E85 / E88
页数：4
相关论文
共 50 条
  • [21] Her2 Amplification Status in Iranian Breast Cancer Patients: Comparison of Immunohistochemistry (IHC) and Fluorescence in situ Hybridisation (FISH)
    Ghaffari, Saeed Reza
    Sabokbar, Tayebeh
    Dastan, Jila
    Rafati, Maryam
    Moossavi, Shirin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 1031 - 1034
  • [22] Concordance of immunohistochemistry and fluorescence in situ hybridization for assessment of HER2 status in breast cancer patients in Xinjiang autonomous region, China
    Zhao, Bing
    Wang, Yu
    Xu, Hang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (10): : 10459 - 10466
  • [23] HER2 status in operable breast cancers from Vietnamese women: Analysis by immunohistochemistry (IHC) and automated silver enhanced in situ hybridization (SISH)
    Vu Hong Thang
    Tani, Edneia
    Ta Thanh Van
    Krawiec, Kamilla
    Skoog, Lambert
    ACTA ONCOLOGICA, 2011, 50 (03) : 360 - 366
  • [24] The spectrum of HER2 expression in breast cancer: linking immunohistochemistry quantification with in situ hybridization assay
    Polonia, Antonio
    Canelas, Carolina
    Caramelo, Ana
    VIRCHOWS ARCHIV, 2022, 480 (06) : 1171 - 1179
  • [25] Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization
    Nakagawa, Tomoe
    Horii, Rie
    Ito, Yoshinori
    Iwase, Takuji
    Akiyama, Futoshi
    BREAST CANCER, 2016, 23 (01) : 78 - 84
  • [26] The Assessment of HER2 Gene Status by Fluorescence In Situ Hybridization in Invasive Breast Carcinomas With Equivocal HER2 Immunostaining: Experience From a Single Institution
    Efared, Boubacar
    Sidibe, Ibrahim S.
    Gamrani, Sana
    El Otmani, Ihsane
    Erregad, Fatimazahra
    Hammas, Nawal
    Bennis, Sanae
    Chbani, Laila
    El Fatemi, Hinde
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2018, 26 (07) : 593 - 599
  • [27] Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast - A single institution experience
    Tubbs, Raymond R.
    Hicks, David G.
    Cook, James
    Downs-Kelly, Erinn
    Pettay, James
    Hartke, Mary Beth
    Hood, LaShonda
    Neelon, Rosemary
    Myles, Jonathan
    Budd, George Thomas
    Moore, Halle C.
    Andresen, Steve
    Crowe, Joseph P.
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2007, 16 (04) : 207 - 210
  • [28] Comparison of HER2 status determination methods in HER2 (2+) patients: Manual fluorescent in situ hybridization (FISH) vs. dual silver enhanced in situ hybridization (SISH)
    Pehlivanoglu, Burcin
    Serin, Gurdeniz
    Yeniay, Levent
    Zekioglu, Osman
    Gokmen, Erhan
    Ozdemir, Necmettin
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 31 : 36 - 40
  • [29] Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study
    van der Logt, Elise M. J.
    Kuperus, Deborah A. J.
    van Setten, Jan W.
    van den Heuvel, Marius C.
    Boers, James. E.
    Schuuring, Ed
    Kibbelaar, Robby E.
    PLOS ONE, 2015, 10 (04):
  • [30] Are There More HER2 FISH in the Sea? An Institution's Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry
    Suydam, Camille
    Chibane, Fairouz
    Brown, Nicole
    Schlafly, Madeleine
    Arnold, Alicia H.
    Ghleilib, Intisar
    Easley, Melissa
    White, Joseph
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 376 - 381
12345